| Methods |
RCT
Method of randomisation: not reported
Assessor blinding: no
Participant blinding: no
Loss to follow‐up: 0
Intention‐to‐treat analysis: no
Post‐program follow up: no |
| Participants |
Location: Sweden
N = 24
Sample: people with moderate to severe CHF
Age: mean 63 years (SD 9) in PRT group
Inclusion criteria: diagnosed with CHF; medically stable CHF in New York Heart Association Class II or III
Exclusion criteria: angina pectoris, valvular heart disease determined by Doppler, co‐morbidity such as intermittent claudication, diabetes mellitus, chronic obstructive pulmonary disease or any other disorder limiting physical performance other than heart failure |
| Interventions |
PRT versus control
1. PRT
Type of Ex: many UL and LL exercises
Equipment: theraband
Intensity: low‐moderate, used Borg rating scale and increased resistance when people rated peripheral resistance <13
Frequency: Ex3
Reps/Sets: 25/2
Program Duration: 8 weeks
Setting: group activity
Supervision: full
Adherence: 95%
2. Control Group: not reported |
| Outcomes |
Aerobic capacity ( Peak VO2 and 6 minute walk test)
Quality of life (Minnesota Living with Heart Failure Index)
Comments on adverse events: yes |
| Notes |
|
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment? |
Unclear risk |
B ‐ Unclear |
